Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study

The purpose of this study is to evaluate the effect of home blood pressure monitoring on controlling blood pressure and correlation between home blood pressure and clinic blood pressure in hypertensive patients receiving two or more concomitant antihypertensive agents including fimasartan

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul national university hospital

Seoul, South Korea

About this study

A multi-center, cluster-randomized, prospective, observational study

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects who voluntarily signed informed consent for participating in this clinical study
Male and female over the age of 19
Hypertensive patients receiving two or more concomitant anti-hypertensive agents including fimasartan

Exclusion criteria

Renal dialysis patients.
Diabetic nephropathy patients taking angiotensin-converting enzyme inhibitor.
Severe renal disorder
Subjects with hereditary disorders of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
Medical history with hypersensitivity to Fimasartan
Pregnant women or lactating female.
Participate in another clinical trial.

Treatment and study plan

Home Blood Pressure

Procedure

Measure Home Blood Pressure

Primary outcomes

Rate of reaching target blood pressure

Time frame: 12 weeks after treatment

Rate of reaching target blood pressure after treatment for 12 weeks

Sponsors and collaborators

Lead sponsor

Boryung Pharmaceutical Co., Ltd

Industry

Registry information

Official study title

A Multi-center, Cluster-randomized, Prospective, Observational Study

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2019
First posted: Aug 21, 2017
Registry last updated: Dec 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed